Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Lung Cancer

Free Subscription 20.07.2020 1 Am J Respir Crit Care Med 1 Ann Surg 1 Ann Thorac Surg 1 Anticancer Res 1 BMC Cancer 2 Cancer Cell 1 Chest 1 Clin Cancer Res 5 Clin Lung Cancer 2 J Cancer Res Clin Oncol 1 J Thorac Cardiovasc Surg 2 J Thorac Oncol 3 Lancet Oncol 4 Lung Cancer 1 Oncologist 3 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. LAM AC, Aggarwal R, Huang J, Varadi R, et al
   Point-Of-Care Spirometry Identifies High-Risk Individuals Excluded from Lung Cancer Screening.
   Am J Respir Crit Care Med. 2020 Jul 16. doi: 10.1164/rccm.202005-1742.
   PubMed        
   
   

   
   Ann Surg

2. PHILLIPS WW, Weiss KD, Digesu CS, Gill RR, et al
   Finding the "True" N0 Cohort: Technical Aspects of Near-infrared Sentinel Lymph Node Mapping in Non-small Cell Lung Cancer.
   Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004176.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

3. SMITH SP, Bograd AJ, Levy G, Chang SC, et al
   Surgical Management of Non-Small Cell Lung Cancer Invading the Fissure: Less Is More?
   Ann Thorac Surg. 2020 Jul 9. pii: S0003-4975(20)31114.
   PubMed         Abstract available
   
   

   
   Anticancer Res

4. PALUMBO B, Capozzi R, Bianconi F, Fravolini ML, et al
   Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With (18)F-FDG-PET/CT.
   Anticancer Res. 2020;40:3355-3360.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. AYE PS, Tin Tin S, McKeage MJ, Khwaounjoo P, et al
   Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand.
   BMC Cancer. 2020;20:658.
   PubMed         Abstract available
   
   

   
   Cancer Cell

6. BEDNAR F, Pasca di Magliano M
   Context-Dependent Immune Responses Explain Pancreatic Cancer Immunoresistance.
   Cancer Cell. 2020;37:261-263.
   PubMed         Abstract available
   
   
7. NG J, Sutherland KD
   NOTCH Your Usual Suspect: MYC Charged with Controlling Neuroendocrine Cell-Fate in Small Cell Lung Cancer.
   Cancer Cell. 2020;38:17-20.
   PubMed         Abstract available
   
   

   
   Chest

8. RAMAN V, Jawitz OK, Voigt SL, Rhodin KE, et al
   The Effect of Tumor Size and Histology on Outcomes Following Segmentectomy vs. Lobectomy for Clinically Node-negative Non-small Cell Lung Cancer.
   Chest. 2020 Jul 8. pii: S0012-3692(20)31868-7. doi: 10.1016/j.chest.2020.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

9. WANG X, Liang JQ, Zhang LH, Gou H, et al
   C8orf76 promotes gastric tumorigenicity and metastasis by directly inducing lncRNA DUSP5P1 and associates with patient outcomes.
   Clin Cancer Res. 2019 Feb 7. pii: 1078-0432.CCR-18-2804.
   PubMed         Abstract available
   
   

   
   Clin Lung Cancer

10. COSTA GJ, Silva GTD, Ferreira CG, Mello MJG, et al
    Brazilian Women With Lung Cancer Have a Higher Overall Survival Than Their Male Equivalents: A Cohort Study.
    Clin Lung Cancer. 2020 Jun 6. pii: S1525-7304(20)30162.
    PubMed         Abstract available
    
    
11. URBANSKA EM, Santoni-Rugiu E, Melchior LC, Carlsen JF, et al
    Intracranial Response of ALK(+) Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery.
    Clin Lung Cancer. 2020 Jun 4. pii: S1525-7304(20)30135.
    PubMed        
    
    
12. RECKAMP KL, Patil T, Kirtane K, Rich TA, et al
    Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis.
    Clin Lung Cancer. 2020 Jun 20. pii: S1525-7304(20)30209.
    PubMed         Abstract available
    
    
13. ENDOH H, Yamamoto R, Ichikawa A, Shiozawa S, et al
    Clinicopathologic Significance of False-Positive Lymph Node Status on FDG-PET in Lung Cancer.
    Clin Lung Cancer. 2020 May 14. pii: S1525-7304(20)30142.
    PubMed         Abstract available
    
    
14. SEHGAL K, Bulumulle A, Brody H, Gill RR, et al
    Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Jun 5. pii: S1525-7304(20)30168.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

15. LATHWAL A, Kumar R, Arora C, Raghava GPS, et al
    Identification of prognostic biomarkers for major subtypes of non-small-cell lung cancer using genomic and clinical data.
    J Cancer Res Clin Oncol. 2020 Jul 14. pii: 10.1007/s00432-020-03318.
    PubMed         Abstract available
    
    
16. BIAN J, Yan K, Liu N, Xu X, et al
    Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2020 Jul 13. pii: 10.1007/s00432-020-03244.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

17. DIMOU A, Nasarre C, Peterson YK, Pagano R, et al
    Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 25. pii: S0022-5223(20)31233.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

18. LEE J, La Choi Y, Han J, Park S, et al
    Osimertinib improves overall survival in EGFR-mutated non-small cell lung cancer patients with leptomeningeal metastases regardless of T790M mutational status.
    J Thorac Oncol. 2020 Jul 8. pii: S1556-0864(20)30505.
    PubMed         Abstract available
    
    
19. ROLFO C, Cardona AF, Ruiz-Patino A, Ariza S, et al
    Atypical skin manifestations during immune checkpoint blockage in COVID19-infected lung cancer patients.
    J Thorac Oncol. 2020 Jul 9. pii: S1556-0864(20)30543.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

20. MIAN I, Padiernos E, Hassan R, Ghafoor A, et al
    Orbital metastases from malignant mesothelioma.
    Lancet Oncol. 2020;21:e117.
    PubMed        
    
    
21. BLAIS E, Troussier I
    Less is more? Imaging-based target volume reduction.
    Lancet Oncol. 2020;21:e302.
    PubMed        
    
    
22. NESTLE U, Schimek-Jasch T, Konig J
    Less is more? Imaging-based target volume reduction - Authors' reply.
    Lancet Oncol. 2020;21:e303.
    PubMed        
    
    

    
    Lung Cancer

23. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
    Lung Cancer. 2020;147:71-76.
    PubMed         Abstract available
    
    
24. GACHECHILADZE M, Skarda J, Skanderova D, Uberall I, et al
    Prognostic value of tumor-infiltrating lymphocytes (TILs) and their association with PD-L1 expression and DNA repair protein RAD51 in patients with resected non-small cell lung carcinoma.
    Lung Cancer. 2020;147:30-38.
    PubMed         Abstract available
    
    
25. SUH JW, Jeong YH, Cho A, Kim DJ, et al
    Corrigendum to "Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer" [Lung Cancer 142 (2020) 28-33].
    Lung Cancer. 2020 Jul 8. pii: S0169-5002(20)30485.
    PubMed        
    
    
26. HAENTSCHEL M, Boeckeler M, Ehab A, Wagner R, et al
    A reply to "A modern approach to Advanced Non-Small Cell Lung Cancer: Minimally-invasive procedures and in parallel multiple DNA/RNA high-throughput sequencing".
    Lung Cancer. 2020 Jul 3. pii: S0169-5002(20)30515.
    PubMed        
    
    

    
    Oncologist

27. NOSAKI K, Yamanaka T, Hamada A, Shiraishi Y, et al
    Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).
    Oncologist. 2020 Jul 12. doi: 10.1634/theoncologist.2020-0640.
    PubMed         Abstract available
    
    

    
    PLoS One

28. CHOI HD, Chang MJ
    Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis.
    PLoS One. 2020;15:e0234818.
    PubMed         Abstract available
    
    
29. LEE CY, Fujino K, Motooka Y, Gregor A, et al
    Photoacoustic imaging to localize indeterminate pulmonary nodules: A preclinical study.
    PLoS One. 2020;15:e0231488.
    PubMed         Abstract available
    
    
30. WARSAVAGE T JR, Xing F, Baron AE, Feser WJ, et al
    Quantifying the incremental value of deep learning: Application to lung nodule detection.
    PLoS One. 2020;15:e0231468.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

31. PHILLIPS JW, Pan Y, Tsai BL, Xie Z, et al
    Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
    Proc Natl Acad Sci U S A. 2020;117:5269-5279.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: